Paulson & Co.
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), John Paulson's Paulson & Co. reported 9 stock positions worth $3.3 billion. Its top holding was Madrigal Pharmaceuticals (MDGL) at 30.5% of the portfolio, followed by Perpetua Resources (PPTA, 24.0%) and Bausch Health Cos (BHC, 15.6%). Compared with Q3 2025, it sold out of 2, added to 3 and reduced 1. The biggest buy was Solstice Adv Materials (SOLS, shares +2692%) and the biggest sale an exit from Honeywell International (HON).
- Most Recent 13F
- Q2 2026
- Notable People
- John Paulson
- Location
- JERSEY CITY, NJ
- CIK
- 0001035674
- Portfolio Value
- $3.3B (Q4 2025)
- SEC Filing
- 0001013594-26-000257 ↗ filed Feb 17, 2026
Holdings Value
Holdings 9 stocks · $3.3B
| MDGL Madrigal Pharmaceuticals Inc. | 30.48% | 1,707,522 | $994.4M | Reduce -10.5% |
| PPTA Perpetua Resources Corp. | 24.01% | 32,347,299 | $783.1M | No change |
| BHC Bausch Health Cos Inc. | 15.61% | 73,255,869 | $509.1M | Add +3.5% |
| AAMI Acadian Asset Management Inc. | 11.16% | 7,743,282 | $363.9M | No change |
| NG Novagold Resources Inc. | 7.78% | 27,238,061 | $253.9M | No change |
| AEM Agnico Eagle Mines Ltd. | 4.07% | 783,561 | $132.8M | No change |
| THM Intl Tower Hill Mines Ltd. filed as INTERNATIONAL TOWER HILL MIN | 4.01% | 70,239,388 | $130.6M | No change |
| SOLS Solstice Adv Materials Inc. | 2.08% | 1,395,787 | $67.8M | Add +2691.6% |
| THRY Thryv Holdings Inc. | 0.81% | 4,347,070 | $26.3M | Add +1.6% |
Portfolio Sells Q3 2025 → Q4 2025
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $2.6B | MDGL, PPTA, AAMI, BHC, THM |
| Q1 2026 | 9 | $3.1B | PPTA, MDGL, AAMI, BHC, NG |
| Q4 2025 | 9 | $3.3B | MDGL, PPTA, BHC, AAMI, NG |
| Q3 2025 | 10 | $3.0B | MDGL, PPTA, BHC, AAMI, NG |
| Q2 2025 | 15 | $2.0B | MDGL, PPTA, AAMI, BHC, NG |
| Q1 2025 | 14 | $1.7B | MDGL, PPTA, AAMI, BHC, AEM |
| Q4 2024 | 13 | $1.7B | MDGL, PPTA, AAMI, BHC, NG |
| Q3 2024 | 15 | $1.4B | MDGL, PPTA, AAMI, BHC, NG |
| Q2 2024 | 16 | $1.4B | MDGL, AAMI, BHC, PPTA, NG |
| Q1 2024 | 18 | $1.4B | MDGL, BHC, AAMI, PPTA, NG |